Zurcher Kantonalbank Zurich Cantonalbank Purchases New Position in CryoPort, Inc. (CYRX)
Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of CryoPort, Inc. (NASDAQ:CYRX) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 12,000 shares of the consumer goods maker’s stock, valued at approximately $118,000.
Several other hedge funds have also modified their holdings of the stock. Northern Trust Corp increased its holdings in CryoPort by 105.0% during the 2nd quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock worth $109,000 after purchasing an additional 11,358 shares during the period. Granite Investment Partners LLC purchased a new position in CryoPort during the 3rd quarter worth $535,000. EAM Investors LLC purchased a new position in CryoPort during the 2nd quarter worth $552,000. D.A. Davidson & CO. increased its holdings in CryoPort by 16.6% during the 2nd quarter. D.A. Davidson & CO. now owns 137,000 shares of the consumer goods maker’s stock worth $674,000 after purchasing an additional 19,500 shares during the period. Finally, Vanguard Group Inc. increased its holdings in CryoPort by 96.9% during the 2nd quarter. Vanguard Group Inc. now owns 519,100 shares of the consumer goods maker’s stock worth $2,554,000 after purchasing an additional 255,519 shares during the period. 18.17% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have commented on the company. Janney Montgomery Scott raised their price objective on CryoPort from $8.00 to $10.00 and gave the stock a “buy” rating in a report on Wednesday, August 9th. Cowen restated an “outperform” rating and set a $11.00 price objective (up from $7.50) on shares of CryoPort in a report on Tuesday, September 12th. Needham & Company LLC raised their price objective on CryoPort from $8.50 to $10.00 and gave the stock a “buy” rating in a report on Wednesday, August 30th. Finally, Roth Capital assumed coverage on CryoPort in a report on Thursday, November 30th. They set a “buy” rating and a $12.50 price objective on the stock. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. CryoPort currently has an average rating of “Buy” and a consensus price target of $33.50.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/12/07/zurcher-kantonalbank-zurich-cantonalbank-purchases-new-position-in-cryoport-inc-cyrx.html.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CryoPort, Inc. (NASDAQ:CYRX).
Receive News & Stock Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related stocks with our FREE daily email newsletter.